Efficacy of Digital Noise Reduction Strategies: A Hearing Aid Trial
1 other identifier
interventional
288
1 country
2
Brief Summary
The purpose of this study is to see if noise reduction programs in digital hearing aids help patients hear better than hearing aids without these programs. We also want to know if we can predict how successful patients will be with hearing aids.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2004
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2004
CompletedFirst Submitted
Initial submission to the registry
December 1, 2005
CompletedFirst Posted
Study publicly available on registry
December 5, 2005
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2006
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2006
CompletedMarch 23, 2010
March 1, 2010
2.5 years
December 1, 2005
March 19, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Words in Noise Test
2 months
Study Arms (1)
1
EXPERIMENTALNoise reduction on
Interventions
Eligibility Criteria
You may qualify if:
- adult onset sensorineural hearing loss
- English as the first language
- bilateral symmetrical sensorineural hearing loss
- Patient is a candidate for directional microphone technology.
- average audiometric thresholds for 500, 1000, 2000, 3000, and 4000 Hz no better than 25-dB HL in either ear.
- no history of hearing aid use in the past 10 years
- appropriate cognitive skills to participate in the study as determined by a passing score on the Mini Mental Scale.
- Patient has a local telephone and address.
You may not qualify if:
- evidence of outer ear, middle ear, or retrocochlear pathology
- any threshold from 500 to 2000 Hz exceeds 70-dB HL
- known neurological or psychiatric disorders as determined by chart review
- known comorbid diseases that would prevent completion of the study as determined by chart review
- visual impairment that would interfere with reading the questionnaires
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
VA Medical Center, Bay Pines
Bay Pines, Florida, 33708, United States
James H. Quillen VA Medical Center
Mountain Home, Tennessee, 37684, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Richard Wilson, PhD
James H. Quillen VA Medical Center
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- FED
Study Record Dates
First Submitted
December 1, 2005
First Posted
December 5, 2005
Study Start
June 1, 2004
Primary Completion
December 1, 2006
Study Completion
December 1, 2006
Last Updated
March 23, 2010
Record last verified: 2010-03